Health News Benefits of HF Drug May Weaken Soon After Withdrawalby News Health July 31, 2025 0 TOPLINE: Finerenone, a third-generation nonsteroidal mineralocorticoid receptor antagonist, showed promise in reducing the incidence of cardiovascular events in patients with heart... Read more